RE:RE:RE:AssessmentPreviously addressed, jackass.....
(ebitda-capex) / net revenue | Protech | Adapthealth | Viemed | Apria |
2020 9 mo | 11.6% | 11.9% | 12.2% | 12.2% |
2019 | 4.7% | 14.3% | 7.6% | 7.4% |
2018 | -3.3% | 13.1% | 5.0% | 4.1% |
2017 | | 10.0% | | 0.3% |
2016 | | 4.4% | | |
besttobe wrote: Ebitda without subtracting Capex for this company is usless. As most of their money is made through leased equipment, which is their second biggest expense outside of wages. So full circle we come, with the same old arguments.
GLTA